A detailed history of Tandem Investment Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tandem Investment Advisors, Inc. holds 3,044 shares of MRK stock, worth $388,779. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,044
Previous 2,242 35.77%
Holding current value
$388,779
Previous $244,000 64.75%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$113.24 - $131.95 $90,818 - $105,823
802 Added 35.77%
3,044 $402,000
Q4 2023

Jan 31, 2024

BUY
$100.18 - $109.02 $25,646 - $27,909
256 Added 12.89%
2,242 $244,000
Q3 2023

Oct 30, 2023

BUY
$102.95 - $114.33 $204,458 - $227,059
1,986 New
1,986 $204,000
Q2 2019

Jul 17, 2019

SELL
$69.84 - $81.59 $184,307 - $215,316
-2,639 Closed
0 $0
Q1 2019

Apr 15, 2019

BUY
$69.58 - $79.36 $183,621 - $209,431
2,639 New
2,639 $219,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tandem Investment Advisors, Inc. Portfolio

Follow Tandem Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tandem Investment Advisors, Inc. with notifications on news.